139 related articles for article (PubMed ID: 36822168)
1. Number Needed to Diagnose in Malignant Ascites: Effects of Volume, Repeating Collection, and Primary Malignancy on Diagnostic Performance in Peritoneal Fluid Cytology.
Ng JKM; Chow LH; Ngai AMY; Chan RCK; Lee JHS; Lee ALH; Li JJX; To CCK; Tse GM
Acta Cytol; 2023; 67(4):434-443. PubMed ID: 36822168
[TBL] [Abstract][Full Text] [Related]
2. Determination of the optimal volume of ascitic fluid for the precise diagnosis of malignant ascites.
Zhang F; Feng Z; Zhang Y; Liu Z; Sun X; Jin S
Saudi J Gastroenterol; 2019; 25(5):327-332. PubMed ID: 30900607
[TBL] [Abstract][Full Text] [Related]
3. A specimen volume of ≥80 mL improves cytologic sensitivity for malignant ascites: a retrospective analysis of 2665 cases.
Rooper LM; Ali SZ; Olson MT
J Am Soc Cytopathol; 2016; 5(5):301-305. PubMed ID: 31042507
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal malignant mesothelioma: Slippery like an eel to diagnose on cytology-case series of 3 cases.
Gupta N; Soni A; Mahajan R; Selhi P; Tyagi R; Garg B; Kaur H
J Am Soc Cytopathol; 2022; 11(1):40-45. PubMed ID: 34602383
[TBL] [Abstract][Full Text] [Related]
5. Practical Approach to the Evaluation of Malignant Peritoneal Fluids in the Setting of Gynecologic Neoplasms.
Mendoza RP; Lastra RR
Acta Cytol; 2023; 67(2):143-175. PubMed ID: 36572015
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Impact of Peritoneal Fluid Cytology in the Setting of Pediatric Uterine Adnexal Biopsy or Resection.
Vadva Z; Laufer MR; Weldon CB; Frazier AL; Vargas SO
Pediatr Dev Pathol; 2016; 19(5):401-408. PubMed ID: 26579785
[TBL] [Abstract][Full Text] [Related]
7. Reassessing the optimal volume for malignancy detection in serous fluid cytology.
Coconubo DM; Baskota SU; Li R; Srivastava P; Cuda J; Khader S
Cancer Cytopathol; 2022 Jul; 130(7):551-557. PubMed ID: 35468659
[TBL] [Abstract][Full Text] [Related]
8. Role of peritoneal ultrasonography and ultrasound-guided fine needle aspiration cytology/biopsy of extravisceral masses in the diagnosis of ascites of undetermined origin.
Allah MH; Salama ZA; El-Hindawy A; Al Kady N
Arab J Gastroenterol; 2012 Sep; 13(3):116-24. PubMed ID: 23122452
[TBL] [Abstract][Full Text] [Related]
9. Role of fibronectin in diagnosis of malignant ascites.
Sood A; Moudgil A; Sood N; Kharay AS; Kaushal S; Narang AP
J Assoc Physicians India; 1997 Apr; 45(4):283-5. PubMed ID: 12521085
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of fibronectin as a marker of malignant ascites.
Siddiqui RA; Kochhar R; Singh V; Rajwanshi A; Goenka MK; Mehta SK
J Gastroenterol Hepatol; 1992; 7(2):161-4. PubMed ID: 1571498
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of carcinoembryonic antigen in malignancy-related ascites: systematic review and meta-analysis.
Ahadi M; Tehranian S; Memar B; Vossoughinia H; Salari M; Eskandari E; Farzanehfar M; Sadeghi R
Acta Gastroenterol Belg; 2014 Dec; 77(4):418-24. PubMed ID: 25682632
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer. Cytologic study of peritoneal washings.
Lei S; Kini J; Kim K; Howard JM
Arch Surg; 1994 Jun; 129(6):639-42. PubMed ID: 8204039
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.
Rana SV; Babu SG; Kocchar R
Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of telomerase activity and cytologic diagnosis in malignant ascites.
Park ES; Lee J; Kang SY; Lee EJ; Lee MH; Yoon N; Oh YL; Kim KM
Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):146-51. PubMed ID: 24344501
[TBL] [Abstract][Full Text] [Related]
15. CEA, AFP and CA 19-9 analysis in peritoneal fluid to differentiate causes of ascites formation.
Kaleta EJ; Tolan NV; Ness KA; O'Kane D; Algeciras-Schimnich A
Clin Biochem; 2013 Jun; 46(9):814-8. PubMed ID: 23454392
[TBL] [Abstract][Full Text] [Related]
16. Significance of epithelial cell clusters in pseudomyxoma peritonei.
Badyal RK; Khairwa A; Rajwanshi A; Nijhawan R; Radhika S; Gupta N; Dey P
Cytopathology; 2016 Dec; 27(6):418-426. PubMed ID: 27121698
[TBL] [Abstract][Full Text] [Related]
17. Cytomorphological changes induced by intraperitoneal chemotherapy present important diagnostic pitfalls in peritoneal fluid cytology.
Mok Y; Nga ME
Cytopathology; 2017 Aug; 28(4):299-306. PubMed ID: 28387003
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of immunohistochemistry staining and cytologic diagnosis by using cell block sections prepared with effusion fluid cytology specimens].
Mao YY; Yang M; Liu DG; Lin MH; Zhang LQ; Chen ZQ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):547-50. PubMed ID: 20021967
[TBL] [Abstract][Full Text] [Related]
19. False-negative peritoneal cytology in metastatic ovarian carcinoma.
Pretorius RG; Lee KR; Papillo J; Baker S; Belinson J
Obstet Gynecol; 1986 Nov; 68(5):619-23. PubMed ID: 3763072
[TBL] [Abstract][Full Text] [Related]
20. Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.
Castaldo G; Oriani G; Cimino L; Topa M; Mostarda I; Castellano L; Del Vecchio-Blanco C; Budillon G; Salvatore F; Sacchetti L
Clin Chem; 1994 Mar; 40(3):478-83. PubMed ID: 8131285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
